JPH047739B2 - - Google Patents
Info
- Publication number
- JPH047739B2 JPH047739B2 JP59231152A JP23115284A JPH047739B2 JP H047739 B2 JPH047739 B2 JP H047739B2 JP 59231152 A JP59231152 A JP 59231152A JP 23115284 A JP23115284 A JP 23115284A JP H047739 B2 JPH047739 B2 JP H047739B2
- Authority
- JP
- Japan
- Prior art keywords
- general formula
- diethyl ether
- mmol
- represented
- hydroxyethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 16
- 150000002466 imines Chemical class 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 7
- 150000001639 boron compounds Chemical class 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 150000003512 tertiary amines Chemical class 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000006239 protecting group Chemical group 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 229910052796 boron Inorganic materials 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 93
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 48
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 23
- 239000002904 solvent Substances 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000010898 silica gel chromatography Methods 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- -1 monocyclic β-lactam Chemical class 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 5
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 5
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 5
- 239000002132 β-lactam antibiotic Substances 0.000 description 5
- 229940124586 β-lactam antibiotics Drugs 0.000 description 5
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 150000003952 β-lactams Chemical group 0.000 description 4
- SVHGAHUUGQJELP-UHFFFAOYSA-N 3-[tert-butyl(dimethyl)silyl]oxybutanoic acid Chemical compound OC(=O)CC(C)O[Si](C)(C)C(C)(C)C SVHGAHUUGQJELP-UHFFFAOYSA-N 0.000 description 3
- NXHUKDCGEGEZCX-UHFFFAOYSA-N 9-borabicyclo[3.3.1]nonan-9-yl trifluoromethanesulfonate Chemical compound C1CCC2CCCC1B2OS(=O)(=O)C(F)(F)F NXHUKDCGEGEZCX-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- WKDDRNSBRWANNC-ATRFCDNQSA-N Thienamycin Chemical compound C1C(SCCN)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 WKDDRNSBRWANNC-ATRFCDNQSA-N 0.000 description 3
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 3
- 125000003460 beta-lactamyl group Chemical group 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- HNIPKGUBNKJRLE-UHFFFAOYSA-N phenylsulfanyl 3-hydroxybutanoate Chemical compound CC(O)CC(=O)OSC1=CC=CC=C1 HNIPKGUBNKJRLE-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 3
- KOXGGQRWBCBIBI-UHFFFAOYSA-N 1-benzyl-3-(1-hydroxyethyl)-4-(2-phenylmethoxyethyl)azetidin-2-one Chemical compound C=1C=CC=CC=1CN1C(=O)C(C(O)C)C1CCOCC1=CC=CC=C1 KOXGGQRWBCBIBI-UHFFFAOYSA-N 0.000 description 2
- ANSYAMHYCYOWAW-UHFFFAOYSA-N 3-phenylmethoxypropanal Chemical compound O=CCCOCC1=CC=CC=C1 ANSYAMHYCYOWAW-UHFFFAOYSA-N 0.000 description 2
- YKIORMQJUHPDNW-UHFFFAOYSA-N 7-(1-hydroxyethyl)-2,2-dimethyl-3-oxa-1-azabicyclo[4.2.0]octan-8-one Chemical compound C1COC(C)(C)N2C(=O)C(C(O)C)C21 YKIORMQJUHPDNW-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- YMQKYTUCHSHLJI-UHFFFAOYSA-N methyl 3-[tert-butyl(dimethyl)silyl]oxybutanoate Chemical compound COC(=O)CC(C)O[Si](C)(C)C(C)(C)C YMQKYTUCHSHLJI-UHFFFAOYSA-N 0.000 description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- VSFDFXVTODBZBR-UHFFFAOYSA-N phenylsulfanyl 3-[tert-butyl(dimethyl)silyl]oxybutanoate Chemical compound CC(C)(C)[Si](C)(C)OC(C)CC(=O)OSC1=CC=CC=C1 VSFDFXVTODBZBR-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- WHMDPDGBKYUEMW-UHFFFAOYSA-N pyridine-2-thiol Chemical compound SC1=CC=CC=N1 WHMDPDGBKYUEMW-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000005185 salting out Methods 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- UKDOTCFNLHHKOF-FGRDZWBJSA-N (z)-1-chloroprop-1-ene;(z)-1,2-dichloroethene Chemical group C\C=C/Cl.Cl\C=C/Cl UKDOTCFNLHHKOF-FGRDZWBJSA-N 0.000 description 1
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 1
- KKODTABNKDRKAY-UHFFFAOYSA-N 2,2-dimethyl-3-oxa-1-azabicyclo[4.2.0]octan-8-one Chemical compound CC1(C)OCCC2CC(=O)N12 KKODTABNKDRKAY-UHFFFAOYSA-N 0.000 description 1
- KMZSRAYQEJTJGC-UHFFFAOYSA-N 2-(1-hydroxyethyl)pentanoic acid Chemical compound CCCC(C(C)O)C(O)=O KMZSRAYQEJTJGC-UHFFFAOYSA-N 0.000 description 1
- NPHULPIAPWNOOH-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(2,3-dihydroindol-1-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCC2=CC=CC=C12 NPHULPIAPWNOOH-UHFFFAOYSA-N 0.000 description 1
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
- GNXPCTNTBWFGIV-UHFFFAOYSA-N 7-[1-[tert-butyl(dimethyl)silyl]oxyethyl]-2,2-dimethyl-3-oxa-1-azabicyclo[4.2.0]octan-8-one Chemical compound C1COC(C)(C)N2C(=O)C(C(O[Si](C)(C)C(C)(C)C)C)C21 GNXPCTNTBWFGIV-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- LDLDJEAVRNAEBW-UHFFFAOYSA-N Methyl 3-hydroxybutyrate Chemical compound COC(=O)CC(C)O LDLDJEAVRNAEBW-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- NZVFQVWFJMHEJN-ULUSZKPHSA-N S-butan-2-yl (3R)-3-hydroxybutanethioate Chemical compound CCC(C)SC(=O)C[C@@H](C)O NZVFQVWFJMHEJN-ULUSZKPHSA-N 0.000 description 1
- MIHSVRIECQOFCF-ZCFIWIBFSA-N S-propan-2-yl (3R)-3-hydroxybutanethioate Chemical compound CC(C)SC(=O)C[C@@H](C)O MIHSVRIECQOFCF-ZCFIWIBFSA-N 0.000 description 1
- PDQYWEQJGDPFHD-ZCFIWIBFSA-N S-propyl (3R)-3-hydroxybutanethioate Chemical compound CCCSC(=O)C[C@@H](C)O PDQYWEQJGDPFHD-ZCFIWIBFSA-N 0.000 description 1
- UTPBRCQFKVGPPW-ZCFIWIBFSA-N S-tert-butyl (3R)-3-hydroxybutanethioate Chemical compound C[C@@H](O)CC(=O)SC(C)(C)C UTPBRCQFKVGPPW-ZCFIWIBFSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- WLLIXJBWWFGEHT-UHFFFAOYSA-N [tert-butyl(dimethyl)silyl] trifluoromethanesulfonate Chemical compound CC(C)(C)[Si](C)(C)OS(=O)(=O)C(F)(F)F WLLIXJBWWFGEHT-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- FAVAVMFXAKZTMV-UHFFFAOYSA-N dibutylboranyl trifluoromethanesulfonate Chemical compound CCCCB(CCCC)OS(=O)(=O)C(F)(F)F FAVAVMFXAKZTMV-UHFFFAOYSA-N 0.000 description 1
- NSZIXDAISDDUFN-UHFFFAOYSA-N dicyclopentylboranyl trifluoromethanesulfonate Chemical compound C1CCCC1B(OS(=O)(=O)C(F)(F)F)C1CCCC1 NSZIXDAISDDUFN-UHFFFAOYSA-N 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- VJHSOSLBABUFPS-UHFFFAOYSA-N n-benzyl-3-(oxan-3-yloxy)propan-1-imine Chemical compound C1CCOCC1OCCC=NCC1=CC=CC=C1 VJHSOSLBABUFPS-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- WVMCKZVPXJTFOE-UHFFFAOYSA-N phenylsulfanyl 3-(benzylamino)-2-(1-hydroxyethyl)-5-phenylmethoxypentanoate Chemical compound C=1C=CC=CC=1SOC(=O)C(C(O)C)C(NCC=1C=CC=CC=1)CCOCC1=CC=CC=C1 WVMCKZVPXJTFOE-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- KMUGAUMHBACBQU-RXMQYKEDSA-N s-ethyl (3r)-3-hydroxybutanethioate Chemical compound CCSC(=O)C[C@@H](C)O KMUGAUMHBACBQU-RXMQYKEDSA-N 0.000 description 1
- PEUCMDBRULVFDB-MRVPVSSYSA-N s-phenyl (3r)-3-hydroxybutanethioate Chemical compound C[C@@H](O)CC(=O)SC1=CC=CC=C1 PEUCMDBRULVFDB-MRVPVSSYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- WMXCDAVJEZZYLT-UHFFFAOYSA-N tert-butylthiol Chemical compound CC(C)(C)S WMXCDAVJEZZYLT-UHFFFAOYSA-N 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
〔発明の目的〕
本発明は一般式
(式中、R1はフエニル基又は低級アルキル基
であり、R2はベンジル基であり、R3は保護基で
ある。)で表わされるβ−アミノチオールエステ
ル及びその製造方法に関する。[Detailed Description of the Invention] [Object of the Invention] The present invention relates to the general formula (In the formula, R 1 is a phenyl group or a lower alkyl group, R 2 is a benzyl group, and R 3 is a protecting group.) and a method for producing the same.
本発明の前記一般式()で表わされるβ−ア
ミノチオールエステルはチエナマイシンなどのカ
ルバペネム系β−ラクタム抗生物質に導くことが
できる。カルバペネム系β−ラクタム抗生物質は
緑濃菌を含むほぼすべての菌に優れた抗菌力を示
し、その強さは従来の薬剤に比べはるかに大きく
かつ、β−ラクタマーゼ安定性も優れている。従
つて第世代のβ−ラクタム抗生物質として多大
な期待が寄せらげている物質群である。
The β-aminothiol ester of the present invention represented by the general formula () can be converted into a carbapenem β-lactam antibiotic such as thienamycin. Carbapenem β-lactam antibiotics exhibit excellent antibacterial activity against almost all bacteria, including Bacillus aeruginosa, and their strength is much greater than that of conventional drugs, and they also have excellent β-lactamase stability. Therefore, they are a group of substances that have great expectations as the next generation of β-lactam antibiotics.
カルバペネム系β−ラクタム抗生物質は醗酵に
よる生産性が低く工業的には化学合成に頼らざる
を得ないので現状である。このことは従来のペニ
シリン、セフアロスポリン系抗生物質と全く異な
る点であると言える。
Currently, carbapenem β-lactam antibiotics have low productivity through fermentation, and industrially they have to rely on chemical synthesis. This can be said to be completely different from conventional penicillin and cephalosporin antibiotics.
現在までに種々のカルバペネム系β−ラクタム
抗生物質が臨床段階にあるがこれらの化合物の基
幹を成す合成中間体としては一般式
(式中、R2及びR3は前記と同様の意味を表わ
す。)で表わされるβ−ラクタムであることが当
業者間において周知の事実である。 To date, various carbapenem β-lactam antibiotics are in the clinical stage, but the synthetic intermediates that form the basis of these compounds are based on the general formula It is a well-known fact among those skilled in the art that it is a β-lactam represented by the formula (wherein R 2 and R 3 have the same meanings as above).
本発明の前記一般式()で表わされるβ−ア
ミノチオールエステルはβ−ラクタム環を形成、
水酸基の保護、さらには保護基の脱保護をするこ
とにより、前記一般式()で表わされる光学活
性β−ラクタムに短工程で導かれ、従つて有用合
成中間体であることが判明した(下記参考例参
照)。 The β-aminothiol ester of the present invention represented by the general formula () forms a β-lactam ring,
By protecting the hydroxyl group and further deprotecting the protecting group, the optically active β-lactam represented by the above general formula ( (See reference example).
従来、前記一般式()で表わされるβ−ラク
タムを製造する方法としては1)光学活性アミノ
酸あるいは酵素による不斉合成を利用して4位に
側鎖を有する単環性β−ラクタム環を構築し、し
かる後に3位側鎖を導入する方法、2)特殊な手
段を利用して3位、4位、1′位に相当する不斉炭
素を選択的に構築後β−ラクタム環を形成する方
法及び3)L−スレオニンや光学活性ペニシリン
等から3位側鎖を有する単環β−ラクタムを構築
し、しかる後に4位側鎖を導入する方法が知られ
ている〔渋谷雅之,有機合成化学協会誌,41,62
(1983)〕。
Conventionally, methods for producing β-lactams represented by the above general formula () include 1) constructing a monocyclic β-lactam ring having a side chain at the 4-position using asymmetric synthesis using optically active amino acids or enzymes; 2) Using special means to selectively construct asymmetric carbons corresponding to the 3-, 4-, and 1'-positions to form a β-lactam ring. Method and 3) A method of constructing a monocyclic β-lactam having a side chain at the 3-position from L-threonine, optically active penicillin, etc. and then introducing a side chain at the 4-position is known [Masayuki Shibuya, Synthetic Organic Chemistry] Association journal, 41 , 62
(1983)].
〔発明が解決しようとする問題点〕
しかしながら前記1)の方法は、3位への側鎖
導入が比較的困難であり、大量合成には不向き
で、工業的製法としては採用しがたい。又、前記
2)の方法は工業的に採用されている方法ではあ
るものの、製造工程が長く、光学分割を含むとい
う欠点を有している。さらに、前記3)の方法
は、光学活性体で目的物は得られるものの製造工
程数が長いという欠点をもつている。[Problems to be Solved by the Invention] However, method 1) above is relatively difficult to introduce a side chain into the 3-position, is unsuitable for large-scale synthesis, and is difficult to adopt as an industrial production method. Furthermore, although method 2) is an industrially adopted method, it has the disadvantage that the manufacturing process is long and includes optical resolution. Furthermore, the method 3) has the disadvantage that although the desired product can be obtained as an optically active substance, the number of manufacturing steps is long.
本発明者等は短工程かつ簡便に前記一般式
()で表わされるβ−ラクタムを合成するため
に有用な前記一般式()で表わされるβ−アミ
ノチオールエステル及び工業的製法を見出し本発
明を完成した。 The present inventors discovered a β-aminothiol ester represented by the above general formula () and an industrial production method useful for synthesizing the β-lactam represented by the above general formula () in a short and simple process, and accomplished the present invention. completed.
本発明の前記一般式()で表わされるβ−ア
ミノチオールエステルは第三級アミンの存在下、
一般式
(式中、R1は前記と同様の意味を表わす。)で
表わされるβ−ヒドロキシチオールエステルと一
般式
(式中、R及びR′はアルキル基、シクロアル
キル基であり、一体となり結合しているホウ素を
伴い環を形成し得る。)で表わされるホウ素化合
物とを反応させ、次いで得られる反応混合物に一
般式
(式中、R2及びR3は前記と同様の意味を表わ
す。)で表わされるイミンを反応させた後過酸化
水素で処理することにより製造するものである。
The β-aminothiol ester of the present invention represented by the above general formula () in the presence of a tertiary amine,
general formula (In the formula, R 1 represents the same meaning as above.) β-hydroxythiol ester represented by the general formula (In the formula, R and R' are an alkyl group or a cycloalkyl group, and can be combined to form a ring together with bonded boron.) Then, the resulting reaction mixture is general formula (In the formula, R 2 and R 3 have the same meanings as above.) It is produced by reacting an imine represented by the formula, followed by treatment with hydrogen peroxide.
前記一般式()で表わされるβ−ヒドロキシ
チオールエステルは、β−ヒドロキシカルボン酸
の水水酸基を保護した後対応するメルカプタンと
の脱水縮合、続いて脱保護することにより容易に
得られる化合物である(下記参考例参照)。前記
一般式()で表わされるβ−ヒドロキシチオー
ルエステルとしては、例えばS−フエニル−3
(R)−ヒドロキシブタンチオエート、S−t−ブ
チル−3(R)−ヒドロキシブタンチオエート、S
−エチル−3(R)−ヒドロキシブタンチオエー
ト、S−sec−ブチル−3(R)−ヒドロキシブタ
ンチオエート、S−n−プロピル−3(R)−ヒド
ロキシブタンチオエート、S−イソプロピル−3
(R)−ヒドロキシブタンチオエート等を使用する
ことができる。一方、前記一般式()で表わさ
れるホウ素化合物は工業的に入手容易であり、例
えば9−ボラビシクロ〔3.3.1〕ノニルトリフル
オロメタンスルホネート、ジシクロペンチルトリ
フルオロメタンスルホニルオキシホウ素、ジ−n
−ブチルトリフルオロメタンスルホニルオキシホ
ウ素等を用いることができる。 The β-hydroxythiol ester represented by the general formula () is a compound that can be easily obtained by protecting the hydroxyl group of β-hydroxycarboxylic acid, followed by dehydration condensation with the corresponding mercaptan, and then deprotection ( (See reference example below). As the β-hydroxythiol ester represented by the general formula (), for example, S-phenyl-3
(R)-hydroxybutanethioate, S-t-butyl-3(R)-hydroxybutanethioate, S
-Ethyl-3(R)-hydroxybutanethioate, S-sec-butyl-3(R)-hydroxybutanethioate, S-n-propyl-3(R)-hydroxybutanethioate, S-isopropyl-3
(R)-Hydroxybutanethioate and the like can be used. On the other hand, boron compounds represented by the general formula () are industrially easily available, such as 9-borabicyclo[3.3.1]nonyltrifluoromethanesulfonate, dicyclopentyltrifluoromethanesulfonyloxyboron, di-n
-butyltrifluoromethanesulfonyloxyboron, etc. can be used.
前記一般式()で表わされるβ−ヒドロキシ
チオールエステルと前記一般式()で表わされ
るホウ素化合物との反応は第三級アミンの存在下
に行うことが必要である。第三級アミンとしては
ジイソプロピルエチアミン、トリエチルアミン、
トリメチルアミン、トリブチルアミンなどを挙げ
ることができるが、反応を効率よく行うにはジイ
ソプロピルエチルアミンを使用することが好まし
い。 The reaction between the β-hydroxythiol ester represented by the general formula () and the boron compound represented by the general formula () needs to be carried out in the presence of a tertiary amine. Tertiary amines include diisopropylethamine, triethylamine,
Examples include trimethylamine and tributylamine, but it is preferable to use diisopropylethylamine in order to carry out the reaction efficiently.
本反応は溶媒中で行うものである。溶媒として
は塩化メチレン、クロロホルム、1,2−ジクロ
ロエチレン等のハロゲン化炭化水素系溶媒、ジエ
チルエーテル、テトラヒドロフラン(THF)、ジ
メトキシエタン(DMF)等のエーテル系溶媒、
トルエン、キシレン等の芳香族系炭化水素を用い
ることができる。 This reaction is carried out in a solvent. Examples of solvents include halogenated hydrocarbon solvents such as methylene chloride, chloroform, and 1,2-dichloroethylene; ether solvents such as diethyl ether, tetrahydrofuran (THF), and dimethoxyethane (DMF);
Aromatic hydrocarbons such as toluene and xylene can be used.
反応は通常−78℃〜室温の範囲で円滑に進行す
る。前記反応により得られる反応混合物は前記一
般式()で表わされるイミンと反応させるもの
である。前記一般式()で表わされるイミンと
してはN−3−ベンジルオキシプロピリデンベン
ジルアミン、N−3−テトラヒドロピラニルオキ
シプロピリデンベンジルアミン、N−3−t−ブ
チルジメチルシリルオオキシプロピリデンベンジ
ルアミン、N−3−トリエチルシリルオキシプロ
ピリデンベンジルアミン等を用いる。 The reaction normally proceeds smoothly at a temperature ranging from -78°C to room temperature. The reaction mixture obtained by the above reaction is reacted with the imine represented by the above general formula (). Examples of the imine represented by the general formula () include N-3-benzyloxypropylidenebenzylamine, N-3-tetrahydropyranyloxypropylidenebenzylamine, and N-3-t-butyldimethylsilyloxypropylidenebenzylamine. , N-3-triethylsilyloxypropylidenebenzylamine, etc. are used.
イミンとの反応の時用いる溶媒はβ−ヒドロキ
シチオールエステルとホウ素化合物との反応の時
用いた溶媒と同じである。 The solvent used in the reaction with the imine is the same as the solvent used in the reaction between the β-hydroxythiol ester and the boron compound.
反応は−78℃〜室温の範囲で容易に進行する。 The reaction proceeds easily between -78°C and room temperature.
本発明はイミンを反応させた後、過酸化水素で
処理することにより前記一般式()で表わされ
るβ−アミノチオールエステルを得るものであ
る。過酸化水素は通常30%程度の水溶液を用い
る。過酸化水素の使用量はβ−ヒドロキシチオー
ルエステルに対し1〜50当量である。過酸化水素
処理に際しては−25℃〜室温に反応液を冷却して
おくことが望ましい。 In the present invention, a β-aminothiol ester represented by the above general formula () is obtained by reacting an imine and then treating it with hydrogen peroxide. A 30% aqueous solution of hydrogen peroxide is usually used. The amount of hydrogen peroxide used is 1 to 50 equivalents based on the β-hydroxythiol ester. During the hydrogen peroxide treatment, it is desirable to cool the reaction solution to -25°C to room temperature.
以下、参考例、実施例により更に本発明を詳細
に説明する。 Hereinafter, the present invention will be further explained in detail with reference to Reference Examples and Examples.
参考例 1
3−ヒドロキシ酪酸メチル5.91g(50mmol)、
イミダゾール3.74g(55mol)を20mlのDMFに溶
かし、これにt−ブチルジメチルシリルクロリド
8.29g(55mmol)を、数回にわけて加えた。室
温で30分間撹拌ののち、氷水を加えジエチルエー
テルで、3回抽出した。抽出液を、飽和食塩水で
洗い、無水硫酸マグネシウムで乾燥ののち減圧下
濃縮した。この濃縮液を蒸留し(62−68℃/
5mmHg)、10.51gの(−)−3−t−ブチルジメ
チルシリルオキシ酪酸メチルを得た。収率91%。Reference example 1 Methyl 3-hydroxybutyrate 5.91g (50mmol),
Dissolve 3.74 g (55 mol) of imidazole in 20 ml of DMF and add t-butyldimethylsilyl chloride.
8.29 g (55 mmol) was added in several portions. After stirring at room temperature for 30 minutes, ice water was added and extracted three times with diethyl ether. The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. This concentrated liquid was distilled (62-68℃/
5 mmHg), 10.51 g of methyl (-)-3-t-butyldimethylsilyloxybutyrate was obtained. Yield 91%.
TLC:0.4(ヘキサン:ジエチルエーテル20:
1)。 TLC: 0.4 (hexane: diethyl ether 20:
1).
IR:(neat)1735cm-1.
NMR:δ0.03,0.06(each 3H;s),0.85
(9H;s),1.20(3H;d J=5),
2.42(2H;m),3.75(3H;s),
4.25(1H;m).
MS:115,133,159〔M−(Me+COOMe)〕,
175〔M−Bu〕,217〔M−Me〕.
〔α〕20 D−31.75゜(c=1.94,CHCl3).
参考例 2
(−)−3−t−ブチルジメチルシリルオキシ
酪酸メチル3.58g(15.4mmol)を、30mlのメタ
ノールに溶かし、1N水酸化カリウム30mlを加え
15時間撹拌した。ほとんどメタノールを留去し、
1N塩酸で酸性化したジエチルエーテルで抽出し
た。抽出液を、飽和食塩水で洗い、無水硫酸マグ
ネシウムで乾燥ののち減圧下濃縮し、3.18gの
(−)−3−t−ブチルジメチルシリルオキシ酪酸
を得た。 IR: (neat) 1735cm -1 . NMR: δ0.03, 0.06 (each 3H; s), 0.85 (9H; s), 1.20 (3H; d J = 5), 2.42 (2H; m), 3.75 (3H ;s), 4.25(1H;m). MS: 115, 133, 159 [M-(Me+COOMe)], 175 [M-Bu], 217 [M-Me]. [α] 20 D −31.75° (c=1.94, CHCl 3 ). Reference example 2 Dissolve 3.58 g (15.4 mmol) of methyl (-)-3-t-butyldimethylsilyloxybutyrate in 30 ml of methanol and add 30 ml of 1N potassium hydroxide.
Stirred for 15 hours. Most of the methanol is distilled off,
Extracted with diethyl ether acidified with 1N hydrochloric acid. The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to obtain 3.18 g of (-)-3-t-butyldimethylsilyloxybutyric acid.
収率95%。Yield 95%.
TLC:0.2(ヘキサン:ジエチルエーテル20:
1)。 TLC: 0.2 (hexane: diethyl ether 20:
1).
IR:(neat)1710cm-1.
NMR:δ0.09,(6H;s),0.88(9H;s),
1.20(3H;d J=6),2.46(2H;dJ=6),
4.27(1H;dt J=6,6).
MS:110,137,197,218〔M〕.
〔α〕20 D−12.50゜(c=0.96.クロロホルム)、
参考例 3
(−)−3−t−ブチルジメチルシリルオキシ
酪酸3.18g(19.2mmol)、チオフエノール2.26ml
(22mmol)を100mlの塩化メチンに溶かしこれ
に、N,N′−ジシククロヘキシルカルボジイミ
ド4.53g(22mmol)を加えた。室温で2時間撹
拌ののち濾過し、濾液を濃縮、蒸留(110−116
℃/0.3mmHg)することにより、(−)−3−t
−ブチルジメチルシリルオキシ酪酸フエニルチオ
エステル5.00g(収率83%)を得た。 IR: (neat) 1710 cm -1 . NMR: δ0.09, (6H; s), 0.88 (9H; s),
1.20 (3H; dJ=6), 2.46 (2H; dJ=6),
4.27 (1H; dt J=6,6). MS: 110, 137, 197, 218 [M]. [α] 20 D −12.50° (c=0.96.chloroform), Reference example 3 (-)-3-t-Butyldimethylsilyloxybutyric acid 3.18g (19.2mmol), thiophenol 2.26ml
(22 mmol) was dissolved in 100 ml of methine chloride and 4.53 g (22 mmol) of N,N'-dicyclohexylcarbodiimide was added thereto. After stirring at room temperature for 2 hours, it was filtered, and the filtrate was concentrated and distilled (110-116
℃/0.3mmHg), (-)-3-t
-Butyldimethylsilyloxybutyric acid phenylthioester 5.00g (yield 83%) was obtained.
TLC:0.3(ヘキサン:ジエチルエーテル20:
1)。 TLC: 0.3 (hexane: diethyl ether 20:
1).
IR(neat)1710cm-1.
NMR:δ0.07(6H;s),0.91(9H;s),1.22
(3H;d J=5),2.61,2.87(each 1H;
dd J=15.7),4.34(1H,m),7.41(5H;
s).
MS:115,159〔M−(Me+COSPh)〕,253〔M
−Bu〕,295〔M−Me〕.
〔α〕20 D−65.91゜(c=0.98,CHCl3).
参考例 4
(−)−3−t−ブチルジメチルシリルオキシ
酪酸218mg(1mmol)、t−ブチルメルカプタン
0.11ml(1mmol)を5mlの塩化メチレンに溶か
し、N,N′−ジシクロヘキシルボジイミド206mg
(1mmol)及びN,N−ジメチルアミノピリジン
5mgを加え室温で3日撹拌した。反応溶液を、10
gのシリカゲルカラムクロマトグラフイー(C−
200;展開溶媒 塩化メチレン)に付し、(−)−
3−t−ブチルジメチルシリルオキシ酪酸−t−
ブチルチオエステルを231mg得た。収率80%。 IR (neat) 1710cm -1 . NMR: δ0.07 (6H; s), 0.91 (9H; s), 1.22
(3H; d J=5), 2.61, 2.87 (each 1H;
dd J=15.7), 4.34 (1H, m), 7.41 (5H;
s). MS: 115, 159 [M-(Me+COSPh)], 253 [M
-Bu], 295 [M-Me]. [α] 20 D −65.91° (c=0.98, CHCl 3 ). Reference example 4 (-)-3-t-Butyldimethylsilyloxybutyric acid 218mg (1mmol), t-butylmercaptan
Dissolve 0.11 ml (1 mmol) in 5 ml of methylene chloride to obtain 206 mg of N,N'-dicyclohexylbodiimide.
(1 mmol) and 5 mg of N,N-dimethylaminopyridine were added, and the mixture was stirred at room temperature for 3 days. Reaction solution, 10
silica gel column chromatography (C-
200; developing solvent methylene chloride), (-)-
3-t-butyldimethylsilyloxybutyric acid-t-
231 mg of butyl thioester was obtained. Yield 80%.
TLC:0.5(ヘキサン:ジエチルエーテル20:
1)。 TLC: 0.5 (hexane: diethyl ether 20:
1).
IR:(neat)1685cm-1.
NMR:δ0.04(6H;s),0.84(9H;s),1.16
(3H;d J=6),1.41(9H:s),2.38,
2.66(each 1H;dd J=15.7)4.26(1H,
m).
MS:119,135,159,177,233〔M−Bu〕,275
〔M−Me〕.
〔α〕20 D−47.65°(c=0.94,CHCl3).
参考例 5
(−)−3−t−ブチルジメチルシリルオキシ
酪酸フエニルチオエステル3.26g(10.4mmol)
に、酢酸:THF:水(3:1:1)50mlを加え、
50℃で24時間間撹拌した。これを、濃縮し、蒸留
(128−130℃/0.8mmHg)することにより、(−)
−3−ヒドロキシ酪酸フエニルチオエステルを
1.91g、収率94%で得た。 IR: (neat) 1685 cm -1 . NMR: δ0.04 (6H; s), 0.84 (9H; s), 1.16
(3H; d J=6), 1.41 (9H:s), 2.38,
2.66 (each 1H; dd J=15.7) 4.26 (1H,
m). MS: 119, 135, 159, 177, 233 [M-Bu], 275
[M-Me]. [α] 20 D −47.65° (c=0.94, CHCl 3 ). Reference example 5 (-)-3-t-Butyldimethylsilyloxybutyric acid phenylthioester 3.26g (10.4mmol)
Add 50 ml of acetic acid:THF:water (3:1:1) to
Stirred at 50°C for 24 hours. By concentrating and distilling this (128-130℃/0.8mmHg), (-)
-3-hydroxybutyric acid phenylthioester
Obtained 1.91 g, yield 94%.
TLC:0.35(ヘキサン:ジエチルエーテル1:
1)。 TLC: 0.35 (hexane: diethyl ether 1:
1).
IR:(neat)3440,1705cm-1.
NMR:δ1.20(3H;d J=6),2.82(2H;d
J=6),3.0(1H;br.s),4.22(1H;m),
7.36(5H;s).
MS:110〔PhSH〕,137〔COSPh〕,196(M).
〔α〕20 D−42.25゜(c=1.42,CHCl3).
参考例 6
(−)−3−ヒドロキシ酪酸−t−ブチルチオ
エステル1.55g(5.3mmol)を、25mlの酢酸:
THF:水(3:1:1)に溶かし50−55℃で、
二日間撹拌した。反応溶液を、減圧下濃縮し40g
のシリカゲルカラムクロマトグラフイー(展開溶
媒ヘキサン:ジエチルエーテル2:1)により精
製し755mg(4.28mmol)の(−)−3−ヒドロキ
シ酪酸−t−ブチルチオエステルを得た。収率80
%。 IR: (neat) 3440, 1705 cm -1 . NMR: δ1.20 (3H; d J=6), 2.82 (2H; d
J=6), 3.0 (1H; br.s), 4.22 (1H; m),
7.36 (5H; s). MS: 110 [PhSH], 137 [COSPh], 196 (M). [α] 20 D −42.25° (c=1.42, CHCl 3 ). Reference example 6 (-)-3-Hydroxybutyric acid-t-butylthioester 1.55g (5.3mmol) and 25ml acetic acid:
Dissolve in THF:water (3:1:1) at 50-55℃.
Stirred for two days. Concentrate the reaction solution under reduced pressure to 40g
The product was purified by silica gel column chromatography (developing solvent: hexane: diethyl ether 2:1) to obtain 755 mg (4.28 mmol) of (-)-3-hydroxybutyric acid-t-butyl thioester. Yield 80
%.
TLC:0.45(ヘキサン:ジエチルエーテル1:
1)。 TLC: 0.45 (hexane: diethyl ether 1:
1).
IR:(neat)3430,1680cm-1.
NMR:δ1.19(3H;d J=6),1.44(9H;
s),2.57(2H;d J=5),3.4(1H;br.
s),4.18(1H;m).
MS:98,120,143,148,177〔M+1〕.
〔α〕20 D−41.83゜(c=1.96,クロロホルム).
実施例 1
3−ベンジルオキシプロピオンアルデヒド820
mg(5.0mmol)、ベンジルアミン0.55ml(5.0m−
mol)、硫酸マグネシウム1gを10mlのジエチル
エーテルに加え、30分撹拌した。反応溶液を濾過
しベンゼンで洗い、濾液を濃縮した。このイミン
はさらに精製することなく、以下の反応に用い
た。 IR: (neat) 3430, 1680 cm -1 . NMR: δ1.19 (3H; d J = 6), 1.44 (9H;
s), 2.57 (2H; d J=5), 3.4 (1H; br.
s), 4.18 (1H; m). MS: 98, 120, 143, 148, 177 [M+1]. [α] 20 D −41.83° (c=1.96, chloroform). Example 1 3-Benzyloxypropionaldehyde 820
mg (5.0 mmol), benzylamine 0.55 ml (5.0 m−
1 g of magnesium sulfate was added to 10 ml of diethyl ether and stirred for 30 minutes. The reaction solution was filtered and washed with benzene, and the filtrate was concentrated. This imine was used in the following reaction without further purification.
(−)−3−ヒドロキシ酪酸フエニルチオエス
テル806mg(4.11mmol)を16mlの塩化メチレンに
溶かし−70℃でジイソプロピルエチルアミン1.50
ml(8.6mmol)、9−BBNトリフレート2.27g
(8.4mmol)を加えた。同温下で30分間、−35℃ま
で15分かけて昇温、−35゜〜−20℃で1時間撹拌の
ち、先に調製したイミンの20mlの塩化メチレン溶
液を、これに加えた。−20℃から5℃まで1.5時間
かけて昇温し、室温でさらに1.5時間撹拌した。
氷浴下に、リン酸緩衝液(PH7.0)20ml、メタノ
ール20ml、35%過酸化水素水10mlを加え同温下で
15分、室温で10分間撹拌ののち塩化メチレンで2
回抽出し、抽出液を、飽和食塩水で洗い、無水硫
酸ナトリウムで乾燥ののち減圧下濃縮した。濃縮
液を、シリカゲルカラムクロマトグラフイー70g
(C−300;展開溶媒 ヘキサン:ジエチルエーテ
ル3:2)、さらに100g(展開溶媒ヘキサン:ジ
エチルエーテル2:1→1:2)で精製し、原料
の(−)−3−ヒドロキシ酪酸フエニルチオエス
テル304mg、3−ベンジルアミノ−5−ベンジル
オキシ−2−(1−ヒドロキシエチル)ペンタン
酸フエニルチオエステル672mgを得た。 Dissolve 806 mg (4.11 mmol) of (-)-3-hydroxybutyric acid phenyl thioester in 16 ml of methylene chloride at -70°C and diisopropylethylamine 1.50 mg.
ml (8.6 mmol), 9-BBN triflate 2.27 g
(8.4 mmol) was added. After heating at the same temperature for 30 minutes, raising the temperature to -35°C over 15 minutes, and stirring at -35° to -20°C for 1 hour, 20ml of the methylene chloride solution of imine prepared previously was added thereto. The temperature was raised from -20°C to 5°C over 1.5 hours, and the mixture was further stirred at room temperature for 1.5 hours.
Add 20 ml of phosphate buffer (PH7.0), 20 ml of methanol, and 10 ml of 35% hydrogen peroxide to an ice bath at the same temperature.
After stirring for 10 minutes at room temperature, diluted with methylene chloride.
The extract was extracted twice, washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. 70g of the concentrated solution was subjected to silica gel column chromatography.
(C-300; developing solvent hexane: diethyl ether 3:2), further purified with 100 g (developing solvent hexane: diethyl ether 2:1 → 1:2), and the raw material (-)-3-hydroxybutyric acid phenylthioester 304 mg and 672 mg of 3-benzylamino-5-benzyloxy-2-(1-hydroxyethyl)pentanoic acid phenylthioester were obtained.
収率36%(原料消費に基づく収率58%)
TLC:0.28(ヘキサン:ジエチルエーテル1:
1)。Yield 36% (58% yield based on raw material consumption) TLC: 0.28 (Hexane: Diethyl ether 1:
1).
IR:(neat)3350,1705cm-1.
NMR:δ1.24(3H;d J=6),2.0(2H,
m),2.98(1H;ddJ=3,6),3.1−3.7
(5H;m),3.68,3.87(each 1H;d J=
13),4.4(1H;m),4.38(2H;s),7.20,
7.23(10H:each s),7.33(5H;s).
MS:145,160,189,200,254,311,340〔M
−SPh〕,358〔M−PhCH2〕.
実施例 2
3−ベンジルオキシプロピオンアルデヒド
1.642g(10.0mmol)、ベンジルアミン1.09ml
(10.0mmol)、硫酸マグネシウム2gを20mlのジ
エチルエーテルに加え、30分撹拌した。反応溶液
を濾過し、ベンゼンで洗い、濾液を濃縮した。こ
のイミンはさらに精製することなく、以下の反応
に用いた。(−)−3−ヒドロキシ酪酸t−ブチル
チオエステル1.492g(8.46mmol)を40mlの塩化
メチレンに溶かし、−70℃でジイソプロピルエチ
ルアミン3.13ml(18mmol)、9−BBNトリフレ
ート4.59g(17mmol)を加えた。同温下で40分、
−25℃〜−10℃で1時間撹拌ののち、先に調整し
たイミンの40ml塩化メチレン溶液を、これに加
え、−10℃−15℃で4時間撹拌した。氷浴下にリ
ン酸緩衝液(PH7.0)60ml、メタノール60ml、31
%過酸化水素水30mlを加え、氷浴で20分、室温で
40分撹拌した。この反応溶液を塩化メチレンで2
回抽出し、抽出液を飽和食塩水で洗い、無水硫酸
ナトリウムで乾燥ののち濃縮した。シリカゲルカ
ラムクロマトグラフイー150g(C−300;展開溶
媒 ジエチルエーテル:ヘキサン2:1)で分離
し、主にベンジルアルキルを不純物として含む3
−ベンジルアミノ−5−ベンジルオキシ−2−
(1−ヒドロキシエチル)ペンタン酸t−ブチル
チオエステル838mgを得た。 IR: (neat) 3350, 1705 cm -1 . NMR: δ1.24 (3H; d J = 6), 2.0 (2H,
m), 2.98 (1H; ddJ=3,6), 3.1−3.7
(5H; m), 3.68, 3.87 (each 1H; d J=
13), 4.4 (1H; m), 4.38 (2H; s), 7.20,
7.23 (10H: each s), 7.33 (5H; s). MS: 145, 160, 189, 200, 254, 311, 340 [M
-SPh], 358 [M- PhCH2 ]. Example 2 3-benzyloxypropionaldehyde
1.642g (10.0mmol), benzylamine 1.09ml
(10.0 mmol) and 2 g of magnesium sulfate were added to 20 ml of diethyl ether and stirred for 30 minutes. The reaction solution was filtered, washed with benzene, and the filtrate was concentrated. This imine was used in the following reaction without further purification. Dissolve 1.492 g (8.46 mmol) of (-)-3-hydroxybutyric acid t-butyl thioester in 40 ml of methylene chloride, and add 3.13 ml (18 mmol) of diisopropylethylamine and 4.59 g (17 mmol) of 9-BBN triflate at -70°C. Ta. 40 minutes at the same temperature,
After stirring at -25°C to -10°C for 1 hour, 40 ml of the previously prepared imine solution in methylene chloride was added thereto, followed by stirring at -10°C to 15°C for 4 hours. 60ml of phosphate buffer (PH7.0), 60ml of methanol in an ice bath, 31
Add 30 ml of % hydrogen peroxide and incubate in an ice bath for 20 minutes at room temperature.
Stirred for 40 minutes. This reaction solution was diluted with methylene chloride.
The extract was extracted twice, washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated. Separated using 150g of silica gel column chromatography (C-300; developing solvent: diethyl ether:hexane 2:1), 3
-benzylamino-5-benzyloxy-2-
838 mg of (1-hydroxyethyl)pentanoic acid t-butylthioester was obtained.
TLC:0.34(ヘキサン:ジエチルエーテル1:
1)。 TLC: 0.34 (hexane: diethyl ether 1:
1).
IR:(neat)3400,1680cm-1.
NMR:δ1.25(3H;d J=6),1.43(9H;
s),2.0(2H;m),2.78(1H;dd J=3,
8),3.1〜3.9(7H;m),4.28(1H;m),
4.42(2H;s),7.21(5H;s),2.23(5H;
s).
MS:254,294,328,338〔M−PhCH2〕,372
〔M−Bu〕,430〔M+1〕.
参考例 7
3−ベンジルアミノ−5−ベンジルオキシ−2
−(1−ヒドロキシエチル)ペンタン酸フエニル
チオエステル752mg(1.67mmol)をTHF10mlに
溶かしこれにt−ブトキシカリウム448mg
(4.0mmol)、水0.2mlのTHF5ml懸濁液を加え、
さらに水0.6mlを加えた。室温で6時間撹拌のの
ち1N塩酸で中和し、反応溶液を塩析しつつ、酢
酸エチルで6回抽出し、有機層を濃縮した。濃縮
液を150mlのアセトニトリルに溶かし、2,2−
ジピリジルジスルフイド440mg(2.0mmol)を加
え、加熱還流下に、トリフエニルフオスフイン
525mg(2.0mmol)のアセトニトリル30ml溶液を
20分かけて滴下し、さらに3時間加熱還流した。
反応溶液を濃縮ののち、60gのシリカゲルカラム
クロマトグラフイー(展開溶媒 ジエチルエーテ
ル)で、2−ピリドチオンを含む目的物の分画を
得、この分画を1N水酸化ナトリウム、水、飽和
食塩水で洗浄し、無水硫酸ナトリウムで乾燥、濃
縮することにより、1−ベンジル−4−(2−ベ
ンジルオキシエチル)−3−(1−ヒドロキシエチ
ル)−2−アゼチジノン410mgを得た。収率72%。 IR: (neat) 3400, 1680 cm -1 . NMR: δ1.25 (3H; d J = 6), 1.43 (9H;
s), 2.0 (2H; m), 2.78 (1H; dd J=3,
8), 3.1-3.9 (7H; m), 4.28 (1H; m),
4.42 (2H; s), 7.21 (5H; s), 2.23 (5H;
s). MS: 254, 294, 328, 338 [M-PhCH 2 ], 372
[M-Bu], 430 [M+1]. Reference example 7 3-benzylamino-5-benzyloxy-2
Dissolve 752 mg (1.67 mmol) of -(1-hydroxyethyl)pentanoic acid phenylthioester in 10 ml of THF and add 448 mg of t-butoxypotassium.
(4.0 mmol), add 5 ml of THF suspension with 0.2 ml of water,
Furthermore, 0.6 ml of water was added. After stirring at room temperature for 6 hours, the mixture was neutralized with 1N hydrochloric acid, and the reaction solution was extracted six times with ethyl acetate while salting out, and the organic layer was concentrated. Dissolve the concentrate in 150 ml of acetonitrile and add 2,2-
Add 440 mg (2.0 mmol) of dipyridyl disulfide, and add triphenyl phosphin under heating to reflux.
A solution of 525 mg (2.0 mmol) in 30 ml of acetonitrile
The mixture was added dropwise over 20 minutes, and the mixture was further heated under reflux for 3 hours.
After concentrating the reaction solution, a fraction of the target product containing 2-pyridothione was obtained using 60 g of silica gel column chromatography (developing solvent: diethyl ether), and this fraction was mixed with 1N sodium hydroxide, water, and saturated saline. By washing, drying over anhydrous sodium sulfate, and concentrating, 410 mg of 1-benzyl-4-(2-benzyloxyethyl)-3-(1-hydroxyethyl)-2-azetidinone was obtained. Yield 72%.
TLC:0.25(ジエチルエーテル)。 TLC: 0.25 (diethyl ether).
IR:(クロロホルム)3460,1735cm-1.
NMR:δ1.23(3H;d J=6),1.8(3H;
m),2.87(8/9H;dd J=6.3),3,14
(1/9H;m),3.3−3.7(3H;m),3.8−4.2
(2H;m),4.32,4.35(2H;each s),4.56
(1H;d J=15),7.23,7.26(10H;each
s)。 IR: (chloroform) 3460, 1735 cm -1 . NMR: δ1.23 (3H; d J = 6), 1.8 (3H;
m), 2.87 (8/9H; dd J=6.3), 3, 14
(1/9H; m), 3.3-3.7 (3H; m), 3.8-4.2
(2H; m), 4.32, 4.35 (2H; each s), 4.56
(1H; d J = 15), 7.23, 7.26 (10H; each
s).
MS:91,146,160,199,201,277,311.
参考例 8
3−ベンジルアミノ−5−ベンジルオキシ−2
−(1−ヒドロキシエチル)ペンタン酸t−ブチ
ルチオエステル(主にベンジルアルキルを不純物
として含む)838mgをTHF20mlに溶かし、これ
に、4N水酸化カリウム1mlを加え、45℃で2日
撹拌した。反応溶液を1N塩酸で中和ののち、塩
析しつつ酢酸エチルで6回抽出し、有機層を濃縮
した。濃縮液を150mlのアセトニトリルに溶かし、
2,2−ジピリジルジスルフイド440mg(2.0m−
mol)、トリフエニルフオスフイン525mg
(2.0mmol)を加え、6時間加熱還流した。反応
溶液を濃縮ののち、60gのシリカゲルカラムクロ
マトグラフイー(展開溶媒 ジエチルエーテル)
で、2−ピリドチオンを含む目的物の分画を得、
この分画を1N水酸化ナトリウム、水、飽和食塩
水で洗浄し、無水硫酸ナトリウムで乾燥、濃縮す
ることにより、1−ベンジ−4−(2−ベンジル
オキシエチル)−3−(1−ヒドロキシエチル)−
2−アゼチジノン51mgを得た。本物質の各種スペ
クトルデータは参考例7で得た1−ベンジル−4
−(2−ベンジルオキシエチル)−3−(1−ヒド
ロキシエチル)−2−アゼチジノンに完全に一致
した。 MS: 91, 146, 160, 199, 201, 277, 311. Reference example 8 3-benzylamino-5-benzyloxy-2
838 mg of -(1-hydroxyethyl)pentanoic acid t-butyl thioester (containing mainly benzyl alkyl as an impurity) was dissolved in 20 ml of THF, 1 ml of 4N potassium hydroxide was added thereto, and the mixture was stirred at 45°C for 2 days. The reaction solution was neutralized with 1N hydrochloric acid, extracted six times with ethyl acetate while salting out, and the organic layer was concentrated. Dissolve the concentrate in 150ml of acetonitrile,
2,2-dipyridyl disulfide 440mg (2.0m-
mol), triphenylfuosufine 525mg
(2.0 mmol) was added, and the mixture was heated under reflux for 6 hours. After concentrating the reaction solution, 60 g of silica gel column chromatography (developing solvent: diethyl ether)
to obtain a fraction of the target product containing 2-pyridothione,
This fraction was washed with 1N sodium hydroxide, water, and saturated brine, dried over anhydrous sodium sulfate, and concentrated to give 1-bendi-4-(2-benzyloxyethyl)-3-(1-hydroxyethyl )−
51 mg of 2-azetidinone was obtained. Various spectral data of this substance are 1-benzyl-4 obtained in Reference Example 7.
-(2-benzyloxyethyl)-3-(1-hydroxyethyl)-2-azetidinone.
参考例 9
1−ベンジル−4−(2−ベンジルオキシエチ
ル)3−(1−ヒドロキシエチル)−2−アゼチジ
ノン100mg(0.3mmol)を、5mlの塩化メチレン
に溶かしこれに2,6−ルチジン0.06ml
(0.5mmol)及びt−ブチルジメチルシリルトリ
フレート0.09ml(0.4mmol)を氷浴下に加え、室
温で5分間撹拌ののち、氷水を加え、塩化メチレ
ンで2回抽出した。抽出液に、硫酸水素ナトリウ
ムを加えルチジンを除去ののち濃縮し、シリカゲ
ルカラムクロマトグラフイー(C−300;10g展
開溶媒ヘキサン:ジエチルエーテル1:1)で精
製し1−ベンジル−4−(2−ベンジルオキシエ
チル)−3−(1−t−ブチルジメチルシリルオキ
シエチル)−2−アゼチジノン128mg(収率89%)
を得た。Reference example 9 Dissolve 100 mg (0.3 mmol) of 1-benzyl-4-(2-benzyloxyethyl)3-(1-hydroxyethyl)-2-azetidinone in 5 ml of methylene chloride and add 0.06 ml of 2,6-lutidine.
(0.5 mmol) and 0.09 ml (0.4 mmol) of t-butyldimethylsilyl triflate were added in an ice bath, and after stirring at room temperature for 5 minutes, ice water was added and extracted twice with methylene chloride. After adding sodium hydrogen sulfate to the extract and removing lutidine, it was concentrated and purified by silica gel column chromatography (C-300; 10 g developing solvent: hexane: diethyl ether 1:1) to obtain 1-benzyl-4-(2- Benzyloxyethyl)-3-(1-t-butyldimethylsilyloxyethyl)-2-azetidinone 128 mg (yield 89%)
I got it.
TLC:0.45(ヘキサン:ジエチルエーテル1:
1)。 TLC: 0.45 (hexane: diethyl ether 1:
1).
IR:(クロロホルム)174cm-1.
NMR:δ0.04,0.08(each 3H;s),0.84
(9H;s),1.14(3H;d J=6),1.8
(2H;m),2.82(8/9H;dd J=2,6),
3.15(1/9H;m),3.35(2H;m),3.67
(1H;m),4.0−4.6(3H;m),4.43(2H;
s),7.24,7.27(10H;eachs).
MS:91,290,396〔M−Bu〕,438〔M−Me〕.
参考例 10
ナトリウム120mgに、液体アンモニアを−70℃
で約5ml加えた。この青色溶液に、3−(1−t
−ブチルジメチルシリルオキシエチル)−4−(2
−ヒドロキシエチル)−2−アゼチジノン99mg
(0.28mmol)のジエチルエーテル2ml溶液を加
え、−70〜−50℃で1時間撹拌ののち、飽和塩化
アンモニウム水溶液を加え0℃まで放置し、ジク
ロロメタンで抽出し、抽出液を、飽和食塩水で洗
い、無水硫酸マグネシウムで乾燥ののち減圧下濃
縮した。10gのシリカゲルカラムクロマトグラフ
イー(C−300;展開溶媒 ジエチルエーテル→
ジエチルエーテル:メタノール20:1)で精製す
ることにより、3−(1−t−ブチルジメチルシ
リルオキシエチル)−4−(2−ヒドロキシエチ
ル)−2−アゼチジノンを59mg収率76%で得た。 IR: (chloroform) 174cm -1 . NMR: δ0.04, 0.08 (each 3H; s), 0.84
(9H; s), 1.14 (3H; d J=6), 1.8
(2H; m), 2.82 (8/9H; dd J=2,6),
3.15 (1/9H; m), 3.35 (2H; m), 3.67
(1H; m), 4.0-4.6 (3H; m), 4.43 (2H;
s), 7.24, 7.27 (10H; eachs). MS: 91, 290, 396 [M-Bu], 438 [M-Me]. Reference example 10 120mg of sodium and liquid ammonia at -70℃
I added about 5 ml. Add 3-(1-t
-butyldimethylsilyloxyethyl)-4-(2
-Hydroxyethyl)-2-azetidinone 99mg
(0.28 mmol) in diethyl ether and stirred at -70 to -50°C for 1 hour. Added a saturated ammonium chloride aqueous solution and allowed to stand at 0°C. Extracted with dichloromethane. The extract was diluted with saturated brine. After washing and drying over anhydrous magnesium sulfate, the mixture was concentrated under reduced pressure. 10g silica gel column chromatography (C-300; developing solvent diethyl ether→
By purification with diethyl ether:methanol (20:1), 59 mg of 3-(1-t-butyldimethylsilyloxyethyl)-4-(2-hydroxyethyl)-2-azetidinone was obtained in a yield of 76%.
TLC:0.17(ジエチルエーテル)。 TLC: 0.17 (diethyl ether).
IR:(クロロホルム)3440,1750cm-1.
NMR:δ0.12(6H;s),0.92(9H;s),1.27
(3H;d J=6),1.88(2H;m),2.55
(1H;br.s),2.91(1H;m),3.74(3H;m),
4.17(1H;m),6.4(1H;br.s).
MS:75,216〔M−Bu〕,258〔M−Me〕.
3−(1−t−ブチルジメチルシリルオキシエ
チル)−4−(2−ヒドロキシエチル)−2−アゼ
チジノンを2,2−ジメトキシプロパン、BF3・
OEt2により7−(1−t−ブチルジメチルシリル
オキシエチル)−2,2−ジメチル−3−オキサ
−1−アザビシクロ〔4.2.0〕オクタン−8−オ
ンに変換し、その後テトラブチルアンモニウムフ
ルオリドで処理すことにより文献(F.A.
Bouffard,D.B.R.Johnston,and B.G.
Christensin,J.Org.Chem.,451130(1980))既知
物質である7−(1−ヒドロキシエチル)−2,2
−ジメチル−3−オキサ−1−アザビシクロ
〔4.2.0〕オクタン−8−オンに導いた。NMRス
ペクトルの比較により7−(1−ヒドロキシエチ
ル)−2,2−ジメチル−3−オキサ−1−アザ
ビシクロ〔4.2.0〕オクタン−8−オンは2種類
の立体異性体の混合物であることが分つた。(比
率約9:1)。主生成物はチエナマイシンをはじ
めとするカルバペネム抗生物物質へ誘導可能な6
(R),7(S)−(1(R)−ヒドロキシエチル)−
2,2−ジメチル−3−オキサ−1−アザビシク
ロ〔4.2.0〕オクタン−8−オンであり、副生成
物は6(R),7(R)−(1(R)−ヒドロキシエチ
ル)−2,2−ジメチル−3−オキサ−1−アザ
ビシクロ〔4.2.0〕オクタン−8−オンであつた。 IR: (chloroform) 3440, 1750 cm -1 . NMR: δ0.12 (6H; s), 0.92 (9H; s), 1.27
(3H; d J=6), 1.88 (2H; m), 2.55
(1H; br.s), 2.91 (1H; m), 3.74 (3H; m),
4.17 (1H; m), 6.4 (1H; br.s). MS: 75, 216 [M-Bu], 258 [M-Me]. 3-(1-t-butyldimethylsilyloxyethyl)-4-(2-hydroxyethyl)-2-azetidinone, 2,2-dimethoxypropane, BF 3 .
Conversion to 7-(1-t-butyldimethylsilyloxyethyl)-2,2-dimethyl-3-oxa-1-azabicyclo[4.2.0]octan-8-one by OEt 2 followed by tetrabutylammonium fluoride. The literature (FA
Bouffard, DBR Johnston, and B.G.
Christensin, J.Org.Chem., 45 1130 (1980)) Known substance 7-(1-hydroxyethyl)-2,2
-dimethyl-3-oxa-1-azabicyclo[4.2.0]octan-8-one. Comparison of NMR spectra shows that 7-(1-hydroxyethyl)-2,2-dimethyl-3-oxa-1-azabicyclo[4.2.0]octan-8-one is a mixture of two stereoisomers. Divided. (Ratio approximately 9:1). The main product is 6 which can be derived into carbapenem antibiotics including thienamycin.
(R),7(S)-(1(R)-hydroxyethyl)-
2,2-dimethyl-3-oxa-1-azabicyclo[4.2.0]octan-8-one, and the by-product is 6(R),7(R)-(1(R)-hydroxyethyl)- It was 2,2-dimethyl-3-oxa-1-azabicyclo[4.2.0]octan-8-one.
参考例 11
参考例10で得たジアステレオマー混合物をシリ
カゲルカラムクロマトグラフイーで分離し、得ら
れた3(S)−〔1(R)−t−ブチルジメチルシリ
ルオキシエチル〕−4(R)−(2−ヒドロキシエチ
ル)−2−アゼチジノン95mg(0.35mmol)を1.5
mlのピリジンに溶かし、クロム酸150mgピリジン
1.5mlより調製したSarett試薬に氷浴下加えた。
室温で一夜撹拌ののち、10gのシリカゲルカラム
クロマトグラフイーにより(展開溶媒 酢酸エチ
ル)無機塩を除去し、トルエンとの共沸によりピ
リジンを除去ののち、シリカゲルカラムクロマト
グラフイー5g(展開溶媒 ジエチルエーテル)
により精製し、3(S)−〔1(R)−t−ブチルジ
メチルシリルオキシエチル〕−4(R)カルボキシ
メチル−2−アゼチノン76mgを得た。収率76%。
分析用サンプルはジエチルエーテルからの再結晶
によつた。Reference example 11 The diastereomer mixture obtained in Reference Example 10 was separated by silica gel column chromatography, and the obtained 3(S)-[1(R)-t-butyldimethylsilyloxyethyl]-4(R)-(2 -Hydroxyethyl)-2-azetidinone 95 mg (0.35 mmol) 1.5
chromic acid 150mg pyridine dissolved in ml pyridine
This was added to 1.5 ml of Sarett's reagent under an ice bath.
After stirring overnight at room temperature, inorganic salts were removed by 10 g of silica gel column chromatography (developing solvent: ethyl acetate), pyridine was removed by azeotropy with toluene, and 5 g of silica gel column chromatography (developing solvent: diethyl ether) was removed. )
to obtain 76 mg of 3(S)-[1(R)-t-butyldimethylsilyloxyethyl]-4(R)carboxymethyl-2-azetinone. Yield 76%.
Analytical samples were recrystallized from diethyl ether.
TLC:0.2(ジエチルエーテル).
mp:151〜154℃(分解).
IR:(クロロホルム)3310,1750,1730cm-1.
NMR:δ0.08(6H;s),0.82(9H;s),1.21
(3H;d J=7),(2.3〜3.0(3H;m),
3.9(1H;m),4.16(2H;m),7.0(1H;br.
s);8.1(1H;br.s).
MS:186,230〔M−Bu〕,272〔M−Me〕.
Anal:計算値C13H25O4NSi
C54.32%,H8.77%,N4.87%.
実測値C54.07%,H8.72%,N4.80%.
〔α〕20 D+16.19゜(c=1.00,クロロホルム).
参考例 12
4(R)−カルボキシメチル−3(S)−〔1(R)
−t−ブチルジメチルシリルオキシエチル〕−2
−アゼチジノン56mg(0.20mmol)、ベンジルアル
コール27mg(0.25mmol)を3mlの塩化メチレン
に溶かし、N,N′−ジシクロロヘキシルカルボ
ジイミド52mg(0.25mmol)と一さじのN,N−
ジメチルアミノピリジンを加え、室温で2時間撹
拌した。反応溶液を濃縮し、10gのシリカゲルカ
ラムクロマトグラフイー(C−300;展開溶媒
ヘキサン:ジエチルエーテル1:2)により精製
し、59mgの4(R)−ベンジルオキシメチル−3
(S)〔1(R)−t−ブチルジメチルシリルオキシ
エチル〕−2−アゼチジノンを得た。収率80%。
分析用のサンプルは、ジエチルエーテル、ヘキサ
ンからの再結晶により得た。 TLC: 0.2 (diethyl ether). mp: 151-154℃ (decomposition). IR: (chloroform) 3310, 1750, 1730 cm -1 . NMR: δ0.08 (6H; s), 0.82 (9H; s), 1.21
(3H; d J=7), (2.3~3.0 (3H; m),
3.9 (1H; m), 4.16 (2H; m), 7.0 (1H; br.
s); 8.1 (1H; br.s). MS: 186, 230 [M-Bu], 272 [M-Me]. Anal: Calculated values C 13 H 25 O 4 NSi C54.32%, H8.77%, N4.87%. Actual values: C54.07%, H8.72%, N4.80%. [α] 20 D +16.19° (c=1.00, chloroform). Reference example 12 4(R)-carboxymethyl-3(S)-[1(R)
-t-butyldimethylsilyloxyethyl]-2
- Dissolve 56 mg (0.20 mmol) of azetidinone and 27 mg (0.25 mmol) of benzyl alcohol in 3 ml of methylene chloride, add 52 mg (0.25 mmol) of N,N'-dicyclohexylcarbodiimide and one teaspoon of N,N-
Dimethylaminopyridine was added and stirred at room temperature for 2 hours. The reaction solution was concentrated, and 10 g of silica gel column chromatography (C-300; developing solvent
59 mg of 4(R)-benzyloxymethyl-3
(S)[1(R)-t-butyldimethylsilyloxyethyl]-2-azetidinone was obtained. Yield 80%.
Samples for analysis were obtained by recrystallization from diethyl ether, hexane.
TLC:0.26(ジエチルエーテル:ヘキサン2:
1).
mp:93.5〜94.5℃
IR:(クロロホルム)3450,1765,1735cm-1.
NMR:δ0.07(6H;s),0.88(9H;s),1.21
(3H;d J=7),2.5〜2.9(3H;m),4.0
(1H;m),4.2(2H;m),5.18(2H;s),
5.95(1H;br.s),7.37(5H;s).
MS:232,276,320〔M−Bu〕.
Anal:計算値C20M31O4NSi
C63.63%,H8.28%,N3.71%,
実測値C63.61%,H8.24%,N3.71%.
〔α〕20 D+16.59゜(c=1,クロロホルム).
参考例 13
4(R)−ベンジルオキシメチル−3(S)−〔1
(R)−t−ブチルジメチルシリルオキシエチル〕
2−アゼチジノン57mg(0.15mmol)に酢酸:
THF:水(3:1:1)2mlを加え50〜60℃で
30時間撹拌した。反応溶液を低温下減圧濃縮し5
gのシリカゲルカラムクロマトグラフイー(C−
200;展開溶媒 酢酸エチル)で精製し、4(R)
−ベンジルオキシメチル−3(S)−〔1(R)−ヒ
ドロキシエチル〕−2−アゼチジノン35mgを得た。
収率89%。 TLC: 0.26 (diethyl ether:hexane 2:
1). mp: 93.5-94.5℃ IR: (Chloroform) 3450, 1765, 1735 cm -1 . NMR: δ0.07 (6H; s), 0.88 (9H; s), 1.21
(3H; d J=7), 2.5-2.9 (3H; m), 4.0
(1H; m), 4.2 (2H; m), 5.18 (2H; s),
5.95 (1H; br.s), 7.37 (5H; s). MS: 232, 276, 320 [M-Bu]. Anal: Calculated value C 20 M 31 O 4 NSi C63.63%, H8.28%, N3.71%, actual value C63.61%, H8.24%, N3.71%. [α] 20 D +16.59° (c=1, chloroform). Reference example 13 4(R)-benzyloxymethyl-3(S)-[1
(R)-t-butyldimethylsilyloxyethyl]
Acetic acid in 2-azetidinone 57mg (0.15mmol):
Add 2ml of THF:water (3:1:1) and heat at 50-60℃.
Stirred for 30 hours. The reaction solution was concentrated under reduced pressure at low temperature.
silica gel column chromatography (C-
200; Purified with 4(R) (developing solvent ethyl acetate)
35 mg of -benzyloxymethyl-3(S)-[1(R)-hydroxyethyl]-2-azetidinone was obtained.
Yield 89%.
〔α〕20 D+9.84゜(c=2.1,クロロホルム).
このものは、文献(D.G.Melillo,T.Liu,K.
Ryan,M.Sletzinger and I.Shinkai
Tetrahedron Lett.22913(1981))に記載されて
いるスペクトルデーターと旋光度を除き完全に一
致した。なお、このものは上に示した文献により
チエナマイシンに導かれている。 [α] 20 D +9.84° (c=2.1, chloroform). This one is based on the literature (DGMelillo, T.Liu, K.
Ryan, M. Sletzinger and I. Shinkai
Tetrahedron Lett. 22 913 (1981)) The spectral data corresponded completely with the data except for the optical rotation. In addition, this substance has been led to thienamycin according to the above-mentioned literature.
旋光度は、文献(N.Ikota,O.Yoshino and
K.Koga Chem.Pharm.Bull301929(1982))の記
載値〔α〕20 D+9.9゜(c=2,3,クロロホルム)
とよい一致を示している。 Optical rotation is determined from the literature (N.Ikota, O.Yoshino and
K.Koga Chem.Pharm.Bull 30 1929 (1982)) stated value [α] 20 D +9.9° (c = 2, 3, chloroform)
shows good agreement.
Claims (1)
中、R1はフエニル基又は低級アルキル基であり、
R2はベンジル基であり、R3は保護基である。)。 2 第三級アミンの存在下、一般式 で表わされるβ−ヒドロキシチオールエステルと
一般式 で表わされるホウ素化合物とを反応させ、次いで
得られる反応混合物に一般式 で表わされるイミンを反応させた後過酸化水素で
処理することからなる、一般式 で表わされるβ−アミノチオールエステルの製造
方法(式中、R1はフエニル基又は低級アルキル
基であり、R2はベンジル基であり、R3は保護基
である。R及びR′はアルキル基、又はシクロア
ルキル基であり、一体となり結合しているホウ素
を伴い環を形成し得る。)。[Claims] 1. General formula β-aminothiol ester represented by (wherein R 1 is a phenyl group or a lower alkyl group,
R 2 is a benzyl group and R 3 is a protecting group. ). 2 In the presence of a tertiary amine, the general formula β-Hydroxythiol ester represented by and the general formula The reaction mixture is then reacted with a boron compound represented by the general formula The general formula consists of reacting the imine represented by and then treating with hydrogen peroxide. A method for producing a β - aminothiol ester represented by , or a cycloalkyl group, which together can form a ring with the bound boron).
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59231152A JPS61109763A (en) | 1984-11-05 | 1984-11-05 | Beta-aminothiol ester and its preparation |
| DE8585113926T DE3563741D1 (en) | 1984-11-05 | 1985-11-01 | Beta-aminothiol ester and process for preparing thereof |
| EP85113926A EP0181581B1 (en) | 1984-11-05 | 1985-11-01 | Beta-aminothiol ester and process for preparing thereof |
| US06/794,893 US4728746A (en) | 1984-11-05 | 1985-11-04 | β-aminothiol ester and process for preparing thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59231152A JPS61109763A (en) | 1984-11-05 | 1984-11-05 | Beta-aminothiol ester and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61109763A JPS61109763A (en) | 1986-05-28 |
| JPH047739B2 true JPH047739B2 (en) | 1992-02-12 |
Family
ID=16919104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59231152A Granted JPS61109763A (en) | 1984-11-05 | 1984-11-05 | Beta-aminothiol ester and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61109763A (en) |
-
1984
- 1984-11-05 JP JP59231152A patent/JPS61109763A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61109763A (en) | 1986-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0586023A (en) | Beta lactam antibiotic intermediate | |
| JP2640986B2 (en) | Process for producing (1'R, 3S) -3- (1'-hydroxyethyl) -azetidin-2-one or a derivative thereof | |
| US4443373A (en) | Process for the production of antibiotic penems | |
| JPS60120885A (en) | Manufacture of penems | |
| CA1256443A (en) | Process for preparing 4-acetoxy-3- hydroxyethylazetidin-2-one derivatives | |
| HU209952B (en) | New process for producing optically active oxazolidine and imidazolidine derivatives | |
| CA1327045C (en) | Azetidinone derivative and process for preparing the same | |
| JPH047739B2 (en) | ||
| US4769451A (en) | Synthesis of carbapenems using n-substituted azetidinones | |
| JPH066570B2 (en) | Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative | |
| Sasaki et al. | Synthetic Studies of Carbapenem and Penem Antibiotics. II. Synthesis of 3-Acetyl-2-azetidinones by (2+ 2) Cycloaddition of Diketene and Schiff Bases | |
| EP0209886B1 (en) | Beta-n-substituted aminothiol ester and process for preparing the same | |
| JPH0358339B2 (en) | ||
| US4740595A (en) | Preparation of azetidinones via N-protected oxirancecarboxamide intermediates | |
| JP3388874B2 (en) | Method for producing β-lactam compound | |
| US4421686A (en) | 4-Norbornyl-sulfonyl azetidinone intermediates and process for preparing (S)-3-acylamino-4-substituted-2-azetidinones | |
| US4728746A (en) | β-aminothiol ester and process for preparing thereof | |
| JPS62116550A (en) | Optically active amino acid derivative | |
| US4973687A (en) | Synthesis of carbapenems using N-substituted azetidinones | |
| JP2620533B2 (en) | New amino acid derivatives | |
| US5089609A (en) | 4-benzoyl azetidinones | |
| US5008404A (en) | Preparation of azetidinones via novel protected intermediates | |
| JPH0649679B2 (en) | Azetidinone derivative | |
| US4827006A (en) | Preparation of azetidinones via novel protected intermediates | |
| JPH0665195A (en) | Novel method for producing β-lactam derivative |